Skip to main content
. 2025 Sep 14;2025:7780635. doi: 10.1155/anrp/7780635

Table 2.

The primary and secondary outcomes of the study.

Dexmedetomidine group (n = 55) Remimazolam group (n = 55) p value
Emergence delirium, n (%) 11 (20.0) 17 (31.0) 0.189
Peak of PAED score 13.6 ± 3.1 13.8 ± 1.1 0.651
RASS, n (%)
 2 2 (3.6) 2 (3.6)
 1 7 (12.7) 4 (7.3)
 0 32 (58.2) 36 (65.5)
 −1 9 (16.4) 8 (14.5)
 −2 5 (9.0) 5 (9.1) 0.671
Spontaneous breathing recovery time (min) 28.2 ± 1.0 28.1 ± 2.3 0.768
Extubation time (min) 32.8 ± 6.9 33.0 ± 5.3 0.119
Length of PACU stay (min) 18.6 ± 11.0 18.0 ± 8.2 0.339
Adverse events, n (%)
 Bradycardia 0 (0) 0 (0)
 SPO2 < 90% 1 (1.8) 3 (5.5)
 SPO2 < 85% 2 (3.6) 2 (3.6)
 Hypotension 0 (0) 0 (0)
 Laryngospasm 1 (1.8) 1 (1.8) 0.175
Parental satisfaction; n (%)
 10 46 (83.6) 42 (76.4)
 9 4 (7.3) 6 (10.9)
 8 4 (7.3) 5 (9.1)
 6 1 (1.8) 2 (3.6) 0.121
PONV, n (%) 5 (9.1) 6 (10.9) 0.751

Note: PAED, Pediatric Anesthesia Emergence Delirium Scale.

Abbreviations: PACU, postanesthesia care unit; PONV, postoperative nausea and vomiting; RASS, Richmond Agitation Sedation Scale.